ArticleBMC cancer2022

Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer.

Flora Nguyen Van Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.